» Articles » PMID: 14585357

Tumor Suppressor P16INK4a Determines Sensitivity of Human Cells to Transformation by Cooperating Cellular Oncogenes

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2003 Oct 31
PMID 14585357
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The Ink4a/Arf locus encodes two distinct proteins, both of which may contribute to senescence and tumor suppression. We find that human diploid fibroblasts (HDFs) that are specifically deficient for p16INK4a achieve anchorage independence when transduced with retroviruses encoding telomerase (hTERT) and either Ras or Myc. Significantly, Ras and Myc together enable the cells to form tumors in nude mice but at a frequency that suggests additional genetic changes. All five tumors analyzed expressed high levels of Ras and retained functional p53, although two showed downregulation of Arf. Cytogenetic analyses identified clonal chromosomal alterations that may have contributed to tumorigenesis, but the tumor cells were essentially diploid.

Citing Articles

Oncogene-Induced Senescence Is a Crucial Antitumor Defense Mechanism of Human Endometrial Stromal Cells.

Toropov A, Deryabin P, Shatrova A, Borodkina A Int J Mol Sci. 2023; 24(18).

PMID: 37762392 PMC: 10531323. DOI: 10.3390/ijms241814089.


MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.

Zhang F, Zakaria S, Hogqvist Tabor V, Singh M, Tronnersjo S, Goodwin J Cell Cycle. 2018; 17(24):2697-2715.

PMID: 30526305 PMC: 6343716. DOI: 10.1080/15384101.2018.1553339.


, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote mRNA stability in human cells.

Cao L, Zhang P, Li J, Wu M Elife. 2017; 6.

PMID: 29199958 PMC: 5739540. DOI: 10.7554/eLife.30433.


The Immortal Senescence.

Bianchi-Smiraglia A, Lipchick B, Nikiforov M Methods Mol Biol. 2016; 1534:1-15.

PMID: 27812863 PMC: 5648013. DOI: 10.1007/978-1-4939-6670-7_1.


A porcine model of osteosarcoma.

Saalfrank A, Janssen K, Ravon M, Flisikowski K, Eser S, Steiger K Oncogenesis. 2016; 5:e210.

PMID: 26974205 PMC: 4815050. DOI: 10.1038/oncsis.2016.19.